Skip Navigation



American Journal of Epidemiology Advance Access published online on October 19, 2006
American Journal of Epidemiology, doi:10.1093/aje/kwj365
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
165/2/115    most recent
kwj365v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Paracchini, V.
Right arrow Articles by Taioli, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paracchini, V.
Right arrow Articles by Taioli, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Copyright © 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A.
Received April 14, 2006
Accepted May 26, 2006

HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEW

Meta- and Pooled Analyses of the Cytochrome P-450 1B1 Val432Leu Polymorphism and Breast Cancer: A HuGE-GSEC Review

Valentina Paracchini 1, Sara Raimondi 1, Inger T. Gram 2, Daehee Kang 3, Neslihan A. Kocabas 4, Vessela N. Kristensen 5, Donghui Li 6, Fritz F. Parl 7, Tove Rylander-Rudqvist 8, Pavel Soucek 9, Wei Zheng 10, Sara Wedren 11, and Emanuela Taioli 12 *

1 Scientific Direction, Ospedale Maggiore, Milan, Italy
2 Department of Preventive Medicine, Faculty of Medicine, Institute of Community Medicine, University of Tromsø, Tromsø, Norway
3 Department of Preventive Medicine, Seoul National University, College of Medicine, Institute of Environmental Medicine, Seoul, South Korea
4 Department of Toxicology, Faculty of Pharmacy, Gazi University, Ankara, Turkey
5 Department of Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo, Norway
6 Department of Gastrointestinal Medical Oncology, M. D. Anderson Cancer Center, University of Texas, Houston, TX
7 Department of Pathology, Vanderbilt University Medical Center, Nashville, TN
8 Division of Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
9 Center of Occupational Diseases, National Institute of Public Health, Prague, Czech Republic
10 Center for Health Services Research, Vanderbilt University Medical Center, Nashville, TN
11 Department of Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
12 University of Pittsburgh Cancer Institute, Pittsburgh, PA

* To whom correspondence should be addressed.
Emanuela Taioli, E-mail: taiolien{at}upmc.edu


  Abstract

The association between the cytochrome P-450 1B1 (CYP1B1) Val432Leu polymorphism and breast cancer was assessed through a meta-analysis of all published case-control studies and a pooled analysis of both published and unpublished case-control studies from the Genetic Susceptibility to Environmental Carcinogens (GSEC) database (http://www.upci.upmc.edu/research/ccps/ccontrol/g_intro.html). GSEC is a collaborative project that gathers information on studies of metabolic gene polymorphisms and cancer. Thirteen articles were included in the meta-analysis (14,331 subjects; 7,514 cases, 6,817 controls); nine data sets were included in the pooled analysis (6,842 subjects; 3,391 cases, 3,451 controls). A summary meta- or pooled estimate of the association between the CYP1B1 Val432Leu polymorphism and breast cancer could not be calculated because of statistically significant heterogeneity in the point estimates among studies. No association between the CYP1B1 Val432Leu polymorphism and breast cancer was observed in Asians (for Val/Val and Val/Leu combined, odds ratio (OR) = 1.0, 95% confidence interval (CI): 0.8, 1.2). An inverse association was observed in populations of mixed/African origin (OR = 0.8, 95% CI: 0.7, 0.9). The pooled analysis suggested a possible association in Caucasians (for Val/Val and Val/Leu combined, OR = 1.5, 95% CI: 1.1, 2.1), with effect modification across age categories. The observed effect of age on the association in Caucasians indicates that further studies are needed on the role of CYP1B1 Val432Leu in estrogen metabolism according to age, ethnicity, and menopausal status.

Keywords: breast neoplasms; CYP1B1; cytochrome P-450 enzyme system; genetics; hormones; meta-analysis; polymorphism, genetic; review [publication type].
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. N. Timofeeva, S. Kropp, W. Sauter, L. Beckmann, A. Rosenberger, T. Illig, B. Jager, K. Mittelstrass, H. Dienemann, The LUCY-Consortium, et al.
CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences
Carcinogenesis, July 1, 2009; 30(7): 1161 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y. Huang, A. Trentham-Dietz, M. Garcia-Closas, P. A. Newcomb, L. Titus-Ernstoff, J. M. Hampton, S. J. Chanock, J. L. Haines, and K. M. Egan
Association of CYP1B1 Haplotypes and Breast Cancer Risk in Caucasian Women
Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1321 - 1323.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
L. M. Dong, J. D. Potter, E. White, C. M. Ulrich, L. R. Cardon, and U. Peters
Genetic Susceptibility to Cancer: The Role of Polymorphisms in Candidate Genes
JAMA, May 28, 2008; 299(20): 2423 - 2436.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.